Can I read GLP-1R Agonists as Wolfram Syndrome Therapy on EtoBox?

GLP-1R Agonists as Wolfram Syndrome Therapy by thaynara.barros is a document available to read on EtoBox.

What is GLP-1R Agonists as Wolfram Syndrome Therapy about?

This study investigates the potential of GLP-1R agonists, specifically dulaglutide and exenatide, as treatments for Wolfram syndrome, a rare genetic disorder characterized by diabetes and neurodegeneration. Results indicate that these agonists improve beta cell function and prevent apoptosis in human models of the disease, suggesting their therapeutic promise. The findings support further exploration of GLP-1R agonists as a viable treatment option for individuals affected by Wolfram syndrome.

Author

thaynara.barros

Language

EN